| Single-cell spatial immune landscapes of primary and metastatic brain tumours E Karimi, MW Yu, SM Maritan, LJM Perus, M Rezanejad, M Sorin, ... Nature 614 (7948), 555-563, 2023 | 178 | 2023 |
| Single-cell spatial landscapes of the lung tumour immune microenvironment M Sorin, M Rezanejad, E Karimi, B Fiset, L Desharnais, LJM Perus, ... Nature 614 (7948), 548-554, 2023 | 156 | 2023 |
| An efficient and flexible cell aggregation method for 3D spheroid production SM Maritan, EY Lian, LM Mulligan Journal of visualized experiments: JoVE, 2017 | 64 | 2017 |
| A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis T Azad, K Nouri, HJ Janse van Rensburg, SM Maritan, L Wu, Y Hao, ... Oncogene 39 (2), 334-355, 2020 | 62 | 2020 |
| Differential roles of RET isoforms in medullary and papillary thyroid carcinomas EY Lian, SM Maritan, JG Cockburn, K Kasaian, MJ Crupi, D Hurlbut, ... Endocr Relat Cancer 24 (1), 53-69, 2017 | 43 | 2017 |
| Invasive growth associated with Cold-Inducible RNA-Binding Protein expression drives recurrence of surgically resected brain metastases M Dankner, M Caron, T Al-Saadi, WQ Yu, V Ouellet, R Ezzeddine, ... Neuro-oncology 23 (9), 1470-1480, 2021 | 26 | 2021 |
| GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion MJF Crupi, SM Maritan, E Reyes-Alvarez, EY Lian, BD Hyndman, ... Oncogene 39 (6), 1361-1377, 2020 | 24 | 2020 |
| RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma EY Lian, BD Hyndman, S Moodley, SM Maritan, LM Mulligan Oncogene 39 (41), 6493-6510, 2020 | 18 | 2020 |
| Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases AM Lazaratos, SM Maritan, A Quaiattini, A Darlix, I Ratosa, E Ferraro, ... The Breast 69, 451-468, 2023 | 10 | 2023 |
| Cancer patient perspectives during the COVID-19 pandemic: a thematic analysis of cancer blog posts MA Hintermayer, M Sorin, JM Romero, SM Maritan, OJ Chen, S Rawal Patient experience journal 7 (3), 31-43, 2020 | 8 | 2020 |
| Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes M Dankner, SM Maritan, N Priego, G Kruck, A Nkili-Meyong, J Nadaf, ... Neuro-oncology 26 (6), 1052-1066, 2024 | 2 | 2024 |
| Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis DJH Bian, AM Lazaratos, SM Maritan, A Quaiattini, Z Zeng, Z Zhu, ... Heliyon 10 (9), 2024 | 2 | 2024 |
| pSTAT3+ stromal cells drive the invasive growth of brain metastases M Dankner, SM Maritan, N Priego, J Nadaf, A Nkili, R Zhuang, G Kruck, ... Cancer Research 82 (12_Supplement), 1569-1569, 2022 | 2 | 2022 |
| OS10. 5. A MINIMALLY INVASIVE BRAIN METASTASES ARE CHARACTERIZED BY AN ACTIVE, ANTI-CANCER IMMUNE INFILTRATE SM Maritan, E Karimi, M Dankner, A Hernandez-Corchado, MW Yu, ... Neuro-Oncology 26 (Supplement_5), v27-v27, 2024 | | 2024 |
| Spatially mapping the single-cell immune landscapes of melanoma brain metastases using imaging mass cytometry. J Magrill, S Allard-Puscas, C Gu, LA Ramsay, M Lajoie, E Karimi, ... Journal of Clinical Oncology 42 (16_suppl), e21517-e21517, 2024 | | 2024 |
| 87P Macrophage ontogeny underlies functional programs and drives brain tumor progression MW Yu, L Wilson, S Doré, L Desharnais, S Maritan, E Karimi, D Zuo, ... ESMO Open 8 (1), 2023 | | 2023 |
| An individual patient-level meta-analysis of non–small-cell lung cancer leptomeningeal metastases treated with epidermal growth factor receptor inhibitors. DJ Bian, AM Lazaratos, SM Maritan, A Quaiattini, Z Zeng, Z Zhu, U Sener, ... Journal of Clinical Oncology 41 (16_suppl), e21118-e21118, 2023 | | 2023 |
| A systematic review and meta-analysis of intrathecal versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases. AM Lazaratos, SM Maritan, A Darlix, I Ratosa, E Ferraro, G Griguolo, ... Journal of Clinical Oncology 41 (16_suppl), 2034-2034, 2023 | | 2023 |
| Minimally invasive brain metastases are characterized by elevated immune cell infiltrate SM Maritan, E Karimi, M Dankner, MW Yu, A Hernandez-Corchado, ... Cancer Research 83 (7_Supplement), 69-69, 2023 | | 2023 |
| Targeting tumor-brain crosstalk in invasive brain metastases C Mourcos, SM Maritan, MG Annis, G Kruck, A Nowakowski, ... Cancer Research 83 (7_Supplement), 3615-3615, 2023 | | 2023 |
